VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,519,139 | +160.9% | 162,128 | +582.9% | 0.01% | +140.0% |
| Q2 2023 | $582,366 | -6.5% | 23,741 | -3.5% | 0.01% | 0.0% |
| Q4 2022 | $622,626 | -55.2% | 24,600 | -65.9% | 0.01% | -58.3% |
| Q3 2022 | $1,390,000 | -12.4% | 72,095 | +15.7% | 0.01% | -20.0% |
| Q2 2022 | $1,587,000 | +413.6% | 62,300 | +419.7% | 0.02% | +400.0% |
| Q1 2022 | $309,000 | -65.4% | 11,987 | -43.7% | 0.00% | -62.5% |
| Q4 2021 | $892,000 | – | 21,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |